PacBio announces $150M public stock offering to fund R&D, commercial expansion

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Proposed offering of $150M common stock; underwriters have 30-day option for additional $22.5M.
Goldman Sachs, Morgan Stanley, Cowen, and Allen & Co. acting as joint book-running managers.
Net proceeds for R&D, commercial infrastructure, working capital, and potential acquisitions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.